Log in

Relevant bibliographies by topics / Coronary heart disease – Treatment / Journal articles

To see the other types of publications on this topic, follow the link: Coronary heart disease – Treatment.

Journal articles on the topic 'Coronary heart disease – Treatment'

Author: Grafiati

Published: 4 June 2021

Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Coronary heart disease – Treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Nurmamadovna, Ishankulova Nasiba. "Coronary Heart Disease." American Journal of Medical Sciences and Pharmaceutical Research 03, no. 02 (February 28, 2021): 31–36. http://dx.doi.org/10.37547/tajmspr/volume03issue02-04.

Full text

Abstract:

The article covers the etiology, pathogenesis, classification, diagnosis, clinical picture and treatment of coronary heart disease, provides a literature review. Cardiovascular disease (CVD) represents the leading cause of death among women as well as men. The number of deaths due to CVD in women are greater than in men. There are significant gender-related differences concerning CVD.

APA, Harvard, Vancouver, ISO, and other styles

2

Knight, C. J. "Antiplatelet treatment in stable coronary artery disease." Heart 89, no. 10 (October 1, 2003): 1273–78. http://dx.doi.org/10.1136/heart.89.10.1273.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ahmed, Dr Ahmed Mohammed, Abdullah Abdulkhaliq Qazzaz, and Dr Hydair Sachet Khalaf. "Ischemic Heart Disease Treatment." International Journal of Research in Science and Technology 12, no. 01 (2022): 39–41. http://dx.doi.org/10.37648/ijrst.v12i01.005.

Full text

Abstract:

Ischemic heart disease IHD is a rapidly increasing common cause of death in the world. This disease is the insufficient status of oxygen within the cardiac muscles due to an imbalance between oxygen supply and demand, and a cardiac disease that occurs as a result of coronary artery stenosis. Ischemic heart disease diseases are the leading cause of death in both developed and developing countries ,among these IHD is the most prevalent manifestation and is associated with high mortality and morbidity. The clinical presentation of IHD include silent ischaemia, stable angina, unstable angina, myocardial infarction, heart failure and sudden death.

APA, Harvard, Vancouver, ISO, and other styles

4

Clappers, N., M. A. Brouwer, and F. W. A. Verheugt. "Antiplatelet treatment for coronary heart disease." Heart 93, no. 2 (December 30, 2005): 258–65. http://dx.doi.org/10.1136/hrt.2005.071209.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Shuper, V. O., S. V. Shuper, I. V. Trefanenko, G. I. Shumko, and T. V. Reva. "Investigation of the Adherence to Prescribed Treatment of the Patients with Coronary Heart Disease." Ukraïnsʹkij žurnal medicini, bìologìï ta sportu 6, no. 5 (October 27, 2021): 263–69. http://dx.doi.org/10.26693/jmbs06.05.263.

Full text

Abstract:

The purpose of the study was to investigate the adherence to secondary prevention medications among patients with coronary heart disease and identify factors associated with it. Materials and methods. We examined 40 patients diagnosed with coronary heart disease of more than 50 years old, who were prescribed with optimal medication for 1 year during hospitalization. Patients` adherence was defined according to MMS-8 Morisky values for secondary prevention medications prescribed by doctors. Also, questionnaires about individual reasons of non-compliance and for individual patient`s opinion about importance and usefulness of knowledge according to risk factors of the increase of cardiovascular mortality were designed and proposed to the patients. Simple descriptive statistics were used to elucidate the characteristics of the patient population and results from individual adherence tools. Final score was analyzed and correlation between patients’ data and level of adherence to prescribed treatment were identified. A correlation matrix (using Spearman’s coefficient) was reviewed for any evidence of collinearity. Results and discussion. Our study demonstrated higher level of non-adherence with secondary prevention medications in patients with coronary heart disease (60.0%). This fact can be explained by the socioeconomic reasons, less informative strategies from the medical staff to the patients. Severe regress of adherence was demonstrated after discharge from the hospital due to subjective improvement of the patients` condition with absence of supervision by out-patient specialists. Demographic characteristics of the patients suggested that some non-modified factors can affect compliance with the prescribed treatment. Better adherence was demonstrated by female married patients with higher educational level, with family history about cardiovascular death. Also, too much prescribed medications with difficult regime of usage with non-adequate out-patient supervision may significantly decrease adherence causing development of complications which may lead to re-hospitalizations and cardiovascular death. Our investigation demonstrated also non-complete information of the patients about lifestyle and medical risk factors of the cardiovascular mortality increase. Conclusion. The results of our study can provide useful practical information on the prevalence and severity of non-adherence among patients with coronary heart disease. Analysis of the factors influencing the adherence demonstrated the main reasons from patients and healthcare professionals affecting the level of compliance with the prescribed treatment. The step towards improving adherence can be initiated by the healthcare professional to overcome the patient's concerns about the prescribed medication. It is important to continue personal monitoring of patients by healthcare professionals in the form of regular inspections of intentional and unintentional non-adherence, including factors and reasons that may change and lead to such behavior

APA, Harvard, Vancouver, ISO, and other styles

6

Korzh, O. M. "CURRENT ASPECTS OF CORONARY HEART DISEASE DIAGNOSIS AND TREATMENT." International Medical Journal, no. 1 (March 5, 2020): 5–10. http://dx.doi.org/10.37436/2308-5274-2020-1-1.

Full text

Abstract:

Among the cardiovascular diseases associated with atherosclerosis, chronic coronary heart disease, including angina, is the most common form. It is the myocardium lesion that develops as a result of an imbalance between the coronary circulation and metabolic needs of heart muscle. The presence of angina symptoms often indicates a pronounced narrowing of one or more coronary arteries, but also occurs in non−obstructive arterial impairment and even in normal coronary arteries. Factors of functional damage to the coronary arteries are spasm, temporary platelet aggregation and intravascular thrombosis. Today there are opportunities not only to use the therapy with proven effectiveness, aimed at reducing the risk of complications, including fatal, but also to treat angina (ischemia), which improves the patient's life quality. The drug protocol includes the ones with a proven positive effect on this disease prognosis, which are mandatory if there are no direct contraindications to use, as well as a large group of antianginal or anti−ischemic drugs. The choice of a particular drug or its combinations with other drugs is carried out in accordance with generally accepted recommendations: taking into account the individual approach, the severity of angina, hemodynamic parameters (heart rate and blood pressure, presence of comorbid conditions). If drug therapy is ineffective, the option of coronary myocardial revascularization (percutaneous coronary angioplasty or coronary artery bypass grafting) is considered. Due to the high mortality and morbidity rates of coronary heart disease worldwide, one of the priorities of practical health care is the prevention of diseases caused by atherosclerosis. Key words: coronary heart disease, angina, family physician, prognosis, drug therapy.

APA, Harvard, Vancouver, ISO, and other styles

7

Cesari, M., G. Rossi, and A. Pessina. "Homocysteine-Lowering Treatment in Coronary Heart Disease." Current Medicinal Chemistry-Cardiovascular & Hematological Agents 3, no. 4 (October 1, 2005): 289–95. http://dx.doi.org/10.2174/156801605774322319.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

LaRosa, John C. "Prevention and Treatment of Coronary Heart Disease." Circulation 104, no. 14 (October 2, 2001): 1688–92. http://dx.doi.org/10.1161/hc3901.096665.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Alpert, Joseph S. "Coronary Heart Disease: Prevention, Complications, and Treatment." JAMA: The Journal of the American Medical Association 253, no. 24 (June 28, 1985): 3609. http://dx.doi.org/10.1001/jama.1985.03350480119039.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Davidson, Karina W. "Depression and Coronary Heart Disease." ISRN Cardiology 2012 (November 22, 2012): 1–18. http://dx.doi.org/10.5402/2012/743813.

Full text

Abstract:

There are exciting findings in the field of depression and coronary heart disease. Whether diagnosed or simply self-reported, depression continues to mark very high risk for a recurrent acute coronary syndrome or for death in patients with coronary heart disease. Many intriguing mechanisms have been posited to be implicated in the association between depression and heart disease, and randomized controlled trials of depression treatment are beginning to delineate the types of depression management strategies that may benefit the many coronary heart disease patients with depression.

APA, Harvard, Vancouver, ISO, and other styles

11

Husein, Muhammad. "The Importance of Heart Rehabilitation for Coronary Heart Disease Patients." Jurnal Ilmiah Kesehatan Keperawatan 15, no. 1 (July 30, 2019): 07. http://dx.doi.org/10.26753/jikk.v15i1.297.

Full text

Abstract:

Coronary heart disease has now become a global cardiovascular problem with a high mortality rate. Regarding the mortality and morbidity rates of patients with high myocardial infarction, appropriate treatment is needed for patients. Three interventions were performed on coronary heart disease patients, thrombolytic interventions, percutaneous coronary intervention, and coronary artery graft bypass (CABG). Cardiac Rehabilitation is a treatment protocol recommended for the treatment of heart disease, and has been developed from a simple multidisciplinary sponsored patient monitoring process that requires patient education, specially designed exercise programs, modification of patient risk factors, and patient benefits. Identifying incentive programs will increase the level of participation in rehabilitation programs, to help patients achieve the main benefits of cardiac rehabilitation

APA, Harvard, Vancouver, ISO, and other styles

12

Frasure-Smith, Nancy, and François Lespérance. "Depression and Coronary Heart Disease." Current Directions in Psychological Science 14, no. 1 (February 2005): 39–43. http://dx.doi.org/10.1111/j.0963-7214.2005.00331.x.

Full text

Abstract:

Beyond depression's impact on life quality, it is associated with both the incidence of coronary heart disease (CHD) and its prognosis. Depression is three times more common in CHD patients than in the general community. It is independently associated with at least a doubling in risk of subsequent cardiac events. Studies also show that it may precede the development of clinically evident CHD by many years. The mechanisms linking depression and CHD are currently unknown and likely to be complex. In addition to behavioral factors, changes in autonomic regulation, vascular disease of the brain, subchronic inflammation, reduced omega-3 free fatty acid levels, and enhanced platelet responsiveness may all be involved. Only one large clinical trial has attempted to alter CHD prognosis by treating depression. It succeeded in producing a small, but significant reduction in depression symptoms, but had no impact on subsequent CHD events. While debate continues about the causal relationship between CHD and depression, the best treatment strategy to improve prognosis in depressed CHD patients remains intensive modification of standard CHD risk factors in combination with treatment of depression to improve life quality.

APA, Harvard, Vancouver, ISO, and other styles

13

Schleiger, Anastasia, Peter Kramer, Stephan Dreysse, Stephan Schubert, Björn Peters, Joachim Photiadis, Felix Berger, and Johannes Nordmeyer. "Coronary Interventions in Pediatric Congenital Heart Disease." Pediatric Cardiology 43, no. 4 (December 13, 2021): 769–75. http://dx.doi.org/10.1007/s00246-021-02784-x.

Full text

Abstract:

Abstract Coronary artery lesions represent rare conditions in pediatric congenital heart disease and mainly include coronary artery stenoses (CAS) or coronary artery fistulae (CAF). Due to the small vessel size, pediatric percutaneous coronary interventions (PCI) are demanding and studies concerning long-term results are missing. In this retrospective study, we analyzed indications, procedural details, and post-procedural outcomes in pediatric patients who underwent PCI in our institution. For CAS treatment, procedural success was defined as efficient coronary revascularization with a significant improvement of coronary perfusion. CAF treatment was considered successful, when no residual shunt was detectable. From 1995 to 2020, 32 pediatric patients aged ≤ 18 years received interventional treatment for CAS (n = 24/32) or CAF (n = 8/32). Reasons for CAS were post-surgical (n = 15/24) or post-transplant (n = 9/24). Interventional treatment strategies included coronary angioplasty (20/43), stent placement (10/43), and a combination of both (13/43). In-hospital mortality occurred in 6/24 patients and late mortality in 5/24 patients leading to an overall 5-year survival of 62.5%. Early mortality mainly occurred due to post-ischemic myocardial failure. CAF occlusion was performed using coil embolization (n = 3), placement of vascular plugs (n = 3), a combination of both (n = 1), or a combination of coil embolization and a covered stent (n = 1). Treatment of coronary fistulae was successful in all patients with excellent post-procedural results and no follow-up death. PCI in pediatric patients with congenital heart disease can be performed safely and effectively. However, the overall 5-year survival probability of patients with CAS is reduced due to severe ischemic myocardial damage.

APA, Harvard, Vancouver, ISO, and other styles

14

Potiyevskaya, Vera, Альберт Ахобеков, Evgenii Khmelevsky, and Elena Kononova. "Radiation-induced ischemic heart disease." Problems in oncology 68, no. 2 (April 30, 2022): 169–77. http://dx.doi.org/10.37469/0507-3758-2022-68-2-169-177.

Full text

Abstract:

Radiation therapy is a widely used treatment for malignant neoplasms of the chest. Radiation-related cardiovascular disease is associated with significant morbidity and mortality. This review discusses the diagnosis and treatment of radiation-induced coronary artery disease. The most common indications for radiotherapy to the mediastinal region are Hodgkin's lymphoma and breast cancer. Hodgkin's lymphoma is one of the most common forms of malignant neoplasms in young people, with an estimated incidence of 3 per 100 000 population and a 10-year survival rate of more than 80%. The incidence of radiation-induced coronary heart disease is about 60% among survivors with Hodgkin's lymphoma 40 years after radiation therapy, and the risk of coronary heart disease and myocardial infarction is 3.2 and 2 times higher, respectively, compared to the general population. Breast cancer is the most common form of malignant neoplasm among women. In 2017, a meta-analysis was published evaluating the effect of radiation therapy for breast cancer on the risk of coronary heart disease and cardiac death. Radiation therapy for breast cancer was associated with an increase in the absolute risk of 76.4 (95% CI 36.8–130.5) cases of coronary heart disease and 125.5 (95% CI 98.8–157.9) cases cardiac death per 100 000 person-years. The risk began to increase during the first decade for death from coronary heart disease and from the second decade for overall death from cardiovascular disease. There is a time lag between exposure to radiation therapy and the development of coronary artery disease. In survivors of Hodgkin's lymphoma, the average time to develop coronary artery disease can range from 2 to 40 years, and in patients with breast cancer, about 9–10 years. Risk factors for radiation-induced coronary artery disease include age at the time of radiation therapy, total radiation dose, amount of tissue exposed, and lack of cardiac shielding techniques.

APA, Harvard, Vancouver, ISO, and other styles

15

Agasiev, A. R. "Influence of concomitant diseases on health resort treatment in patients with coronary heart disease." Kazan medical journal 96, no. 5 (October 15, 2015): 744–48. http://dx.doi.org/10.17750/kmj2015-744.

Full text

Abstract:

Aim. To study the influence of concomitant diseases on health resort treatment of patients with coronary heart disease in recreation period. Methods. The study performed in «Bilgah» cardiologic resort, which applies the standards of health resort treatment. General sample included 3421 patients with confirmed diagnosis of «coronary heart disease». Patients were grouped according to the number of concomitant diseases (0, 1, 2, 3 or more). In each group, the frequency of prescribing the certain treatment methods was determined. Results. The vast majority (94.5±0.4%) of patients with coronary heart disease had one or more associated chronic diseases. The proportion of patients with 1, 2, 3, 4, 5, 6 or more chronic diseases was 60.3±0.8; 13.7±0.6; 6.0±0.4; 5.5±0.4; 5.1±0.4 and 0.3±3.9% respectively. In addition to the main disease, a patient had 1.77 compensated chronic diseases in average. There were 56.4±0.85 cases of arterial hypertension, 29.7±0.78 cases of respiratory diseases, 26.8±0.76 cases of gastrointestinal diseases (excluding dental and other diseases of the oral cavity), 23.7±0.73 cases of genitourinary diseases, 18.6±0.66 cases of musculoskeletal system diseases, 9.2±0.49 cases of diabetes on average in 100 patients. In 100 patients with coronary heart disease and 1, 2, 3-4, 5 or more chronic comorbidities were administered 474.8, 524.5, 542.4 and 617.7 treatment methods, respectively. Conclusion. In patients with coronary heart disease, comorbidities are often identified, requiring administration of additional treatment methods, indicating that polymorbidity is an objective reason for the increased volume of medical services at health resort treatment.

APA, Harvard, Vancouver, ISO, and other styles

16

Korzh, O. M. "Evolution of approaches to the treatment of acute coronary syndromes: from Eisenhower's heart attack to modern approaches to treatment." Shidnoevropejskij zurnal vnutrisnoi ta simejnoi medicini 2022, no. 2 (2022): 72–76. http://dx.doi.org/10.15407/internalmed2022.02.072.

Full text

Abstract:

US President Dwight Eisenhower suffered an acute myocardial infarction in 1955. But in Eisenhower’s case, the beginning was unusual. Furthermore, ECGs were not widely available, cardiac enzymes were not used as diagnostic tests, and echocardiography or coronary angiography were not available to emergency physicians or cardiologists. In the half century since Eisenhower’s heart attack, pioneering physicians have discovered and developed coronary arteriography, coronary bypass surgery, balloon coronary angioplasty, and coronary stents, discoveries that have greatly improved the outlook for patients with coronary heart disease. It revolutionized the treatment of coronary heart disease half a century after Eisenhower’s heart attack. Former President Bill Clinton is one of the millions who have benefited from these discoveries.

APA, Harvard, Vancouver, ISO, and other styles

17

Berry, Colin. "Interview: New treatment approaches in coronary heart disease." Interventional Cardiology 5, no. 1 (February 2013): 17–19. http://dx.doi.org/10.2217/ica.12.83.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Denollet, Johan, Johan Vaes, and Dirk L. Brutsaert. "Inadequate Response to Treatment in Coronary Heart Disease." Circulation 102, no. 6 (August 8, 2000): 630–35. http://dx.doi.org/10.1161/01.cir.102.6.630.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Ebrahim, S., G. D. Smith, C. McCabe, N. Payne, M. Pickin, T. A. Sheldon, F. Lampe, F. Sampson, S. Ward, and G. Wannamthee. "Cholesterol and coronary heart disease: screening and treatment." Quality and Safety in Health Care 7, no. 4 (December 1, 1998): 232–39. http://dx.doi.org/10.1136/qshc.7.4.232.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Stone, AF, MA Mendall, AJ Camm, and TC Northfield. "Antibiotics in the Treatment of Coronary Heart Disease." Clinical Science 100, s44 (February 1, 2001): 1P—2P. http://dx.doi.org/10.1042/cs100001pb.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

ERWES, H., and H. BENN. "Fendiline in the treatment of coronary heart disease." Journal of Molecular and Cellular Cardiology 19 (1987): S21. http://dx.doi.org/10.1016/s0022-2828(87)80070-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Elisaf, Moses. "The Treatment of Coronary Heart Disease: An Update." Current Medical Research and Opinion 17, no. 1 (January 2001): 18–26. http://dx.doi.org/10.1185/0300799039117021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Kolovou, Genovefa. "The Treatment of Coronary Heart Disease: An Update." Current Medical Research and Opinion 17, no. 1 (January 2001): 34–37. http://dx.doi.org/10.1185/0300799039117023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Cokkinos, Dennis V. "The Treatment of Coronary Heart Disease: An Update." Current Medical Research and Opinion 17, no. 1 (January 2001): 38–40. http://dx.doi.org/10.1185/0300799039117024.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Sacks, Frank M. "High-Intensity Statin Treatment for Coronary Heart Disease." JAMA 291, no. 9 (March 3, 2004): 1132. http://dx.doi.org/10.1001/jama.291.9.1132.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Shreen, Sara, Mohammed Baleeqh Uddin, Mir Salman Ali, and Zoha Sultana. "The Role of Antiplatelet agents in ischemic events." Journal of Drug Delivery and Therapeutics 11, no. 4-S (August 15, 2021): 187–94. http://dx.doi.org/10.22270/jddt.v11i4-s.4926.

Full text

Abstract:

Antiplatelet treatment could be a key in pharmacological treatment for avoidance of coronary heart disease (CHD) and stroke. Depending on sign, term of antiplatelet monotherapy or double treatment is shifted. Antiplatelet treatment is shown to avoid a repeat of cardiovascular occasion, in any case, expanded term of dual antiplatelet treatment (DAPT) related with expanded hazard of bleeding. Unstable angina happens due to partially or totally block of the blood coronary blood vessel driving to coronary ischaemia. Intense coronary infection happens due to drawn out coronary ischaemia which causes coronary diseases. Keywords: dual antiplatelet treatment (DAPT), coronary heart disease (CHD) and stroke.

APA, Harvard, Vancouver, ISO, and other styles

27

King, S. B., and B. Meier. "Interventional Treatment of Coronary Heart Disease and Peripheral Vascular Disease." Circulation 102, Supplement 4 (November 14, 2000): IV—81—IV—86. http://dx.doi.org/10.1161/01.cir.102.suppl_4.iv-81.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Dianirani, Afrina Safira, and Zefanya Debby Claudia. "Fuzzy-based Decision for Coronary Heart Disease Diagnosis: Systematic Literature Review." Engineering, MAthematics and Computer Science (EMACS) Journal 3, no. 2 (May 31, 2021): 73–78. http://dx.doi.org/10.21512/emacsjournal.v3i2.6939.

Full text

Abstract:

Coronary heart disease is usually caused by a buildup of fatty material and plaque inside the coronary arteries. The death rate caused by coronary heart diseases is threatening around the world. For the past two decades, most of the people from developing countries are suffering from heart disease. Diagnosing these diseases at earlier stages helps patients reduce the risk of death and also in reducing the cost of treatment. Decisions in medical diagnosis are mostly taken by expert’s experiences. In many cases, not all the expert’s experiences contribute towards effective diagnosis of a disease. Many alternative methods have been suggested for medical diagnosis in the healthcare domain. However, evaluating the functionality of coronary heart diseases diagnosis systems remains challenging. The purpose of this paper is to perform a study on literature related to fuzzy-based decision for diagnosis of coronary heart disease. Accordingly, the research gathered studies related to fuzzy-based decision for diagnosis of coronary heart disease between the periode 2016-2021.

APA, Harvard, Vancouver, ISO, and other styles

29

Akchurin, R. S., E. E. Vlasova, and K. V. Mershin. "DIABETUS MELLITUS AND SURGICAL TREATMENT OF CORONARY HEART DISEASE." Annals of the Russian academy of medical sciences 67, no. 1 (January 22, 2012): 14–19. http://dx.doi.org/10.15690/vramn.v67i1.104.

Full text

Abstract:

Nearly 40-year experience of surgical treatment of coronary heart disease testifies to higher coronary heart disease (CHD) morbidity and mortality rates among diabetes mellitus patients in comparison to non-diabetic patients. At the same time, comparative study of CHD treatment methods efficacy in diabetes mellitus patients has shown that surgery is preferred to angioplasty, especially in the most severe cases – in presence of coronary occlusion, insulin-dependent diabetes and left-ventricle dysfunction. More inferior results of coronary bypass surgery in diabetic patients in comaparison to non-diabetic were conditional on a more pronounced arterial calcinosis and diffuse distal arterial involvement, as well as more severe aortal ateromatosis, flebopathy and more often wound infection occurrence. In the department of cardio-vascular surgery in Russian cardiologic scientific productive complex a quarter of all patients waiting for the coronary bypass surgery are diabetic. Selection algorithm, preoperation preparation, peculiarities of surgical technique and principles of postoperative supervision of these patients were specially designed. With adequate preparation, remission of diabetes and use of microsurgery, postoperative prognosis for these patients (both stratified and real) is comparative to that for the main group of patients. One-year follow up after the bypass surgery data testifies to the low difference in autovenous and autoarterial shunt patency in diabetic and non-diabetic patients. Long-term (10 years) survival rate is significantly lower in the group of diabetic patients. Proposed cardioprotective postoperative strategy is designed to improve both short and long-term efficacy of surgical revascularization in CHD patients with concomitant diabetes mellitus.

APA, Harvard, Vancouver, ISO, and other styles

30

Verma, Niharika. "INTRODUCTION TO HYPERLIPIDEMIA AND ITS TREATMENT: A REVIEW." International Journal of Current Pharmaceutical Research 9, no. 1 (December 31, 2016): 6. http://dx.doi.org/10.22159/ijcpr.2017v9i1.16616.

Full text

Abstract:

Hyperlipidemia is a family of disorders that are characterised by abnormally high levels of lipida (fats) in the blood. While fats play a vital role in the body’s metabolic processes, high blood levels of fats increase the risk of coronary heart disease (CHD). Cardiovascular diseases, especially coronary heart disease (CHD), are epidemic in India. According to American Heart Association, the Centres for Disease Control and Prevention, the National Institutes of Health and other government sources, cardiovascular disease is the leading global cause of death, accounting for more than 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. India has seen a rapid transition in its heart disease burden over the past couple of decades. Of the 30 million heart patients in India, 14 million reside in urban areas and 16 million in rural areas. If the current trend continues, by the year 2020, the burden of atherothrombotic cardiovascular diseases in India will surpass that of any other country in the world. The Registrar General of India reported that CHD led to 17% of total deaths and 26% of adult deaths in 2001-2003, which increased to 23% of total and 32% of adult deaths in 2010-2013. The global increase in the prevalence of hyperlipidemia is due to unhealthy eating habits, obesity and physical inactivity. The emergencies, risk factors and remedies are described in the literature. Hyperlipidemia, Coronary heart disease, lipoproteins

APA, Harvard, Vancouver, ISO, and other styles

31

Carpio, Carlos, Rodolfo Álvarez-Sala, and Francisco García-Río. "Epidemiological and Pathogenic Relationship between Sleep Apnea and Ischemic Heart Disease." Pulmonary Medicine 2013 (2013): 1–8. http://dx.doi.org/10.1155/2013/405827.

Full text

Abstract:

Obstructive sleep apnea is recognized as having high prevalence and causing remarkable cardiovascular risk. Coronary artery disease has been associated with obstructive sleep apnea in many reports. The pathophysiology of coronary artery disease in obstructive sleep apnea patients probably includes the activation of multiple mechanisms, as the sympathetic activity, endothelial dysfunction, atherosclerosis, and systemic hypertension. Moreover, chronic intermittent hypoxia and oxidative stress have an important role in the pathogenesis of coronary disease and are also fundamental to the development of atherosclerosis and other comorbidities present in coronary artery diseases such as lipid metabolic disorders. Interestingly, the prognosis of patients with coronary artery disease has been associated with obstructive sleep apnea and the severity of sleep disordered breathing may have a direct relationship with the morbidity and mortality of patients with coronary diseases. Nevertheless, treatment with CPAP may have important effects, and recent reports have described the benefits of obstructive sleep apnea treatment on the recurrence of acute heart ischaemic events in patients with coronary artery disease.

APA, Harvard, Vancouver, ISO, and other styles

32

Aquarista, Nindara Citra. "Differences Characteristics Patients Diabetes Mellitus Type 2 with and without Coronary Heart Disease." Jurnal Berkala Epidemiologi 5, no. 1 (April 28, 2017): 37. http://dx.doi.org/10.20473/jbe.v5i1.2017.37-47.

Full text

Abstract:

Diabetes mellitus is the third highest Non-Communicable Diseases (NCDs), which causes death in Indonesia. The incidence of coronary heart disease in diabetes mellitus is high, 65% of people with diabetes mellitus die due to coronary heart disease and stroke. The purpose of this study is to analyze the differences in the characteristics of Diabetes mellitus type 2 in patients with and without coronary heart disease in Haji General Hospital Surabaya year 2016. This research uses observational analysis with cross sectional study design.The subject of the study is the incidence of diabetes Mellitus type 2 with and without coronary heart disease with undergoing outpatient treatment at Haji General Hospital Surabaya year 2016. The Samples were taken by fixed-disease sampling method with 42 people as the samples. The data analysis uses Chi Square test. The results show for the independent variables that have the most significant difference inHaji General Hospital Surabaya year 2016 is smoking behavior (p = 0.00; PR = 7.85; 95% CI = 2.09 to 29.50) and hypertension (p= 0,002; PR = 3.51; 95% CI = 1.42 to 8.67). In conclusion, the smoking behavior and hypertension can lead to complications of coronary heart disease for patients with type in Diabetes Mellitus type 2 in Haji General Hospital year 2016. It needs awareness to check blood pressure regularly and eliminate the smoking habit as the prevention of complications of coronary heart disease for patients with diabetes mellitus type 2.Keywords: diabetes mellitus type 2, coronary hearth disease.

APA, Harvard, Vancouver, ISO, and other styles

33

Aquarista, Nindara Citra. "Differences Characteristics Patients Diabetes Mellitus Type 2 with and without Coronary Heart Disease." Jurnal Berkala Epidemiologi 5, no. 1 (April 28, 2017): 37. http://dx.doi.org/10.20473/jbe.v5i12017.37-47.

Full text

Abstract:

Diabetes mellitus is the third highest Non-Communicable Diseases (NCDs), which causes death in Indonesia.The incidence of coronary heart disease in diabetes mellitus is high, 65% of people with diabetes mellitus die due to coronary heart disease and stroke. The purpose of this study is to analyze the differences in the characteristics of Diabetes mellitus type 2 in patients with and without coronary heart disease in Haji General Hospital Surabaya year 2016. This research uses observational analysis with cross sectional study design. The subject of the study is the incidence of diabetes Mellitus type 2 with and without coronary heart disease with undergoing outpatient treatment at Haji General Hospital Surabaya year 2016. The Samples were taken by fixed-disease sampling method with 42 people as the samples. The data analysis uses Chi Square test. The results show for the independent variables that have the most significant difference inHaji General Hospital Surabaya year 2016 is smoking behavior (p = 0.00; PR = 7.85; 95% CI = 2.09 to 29.50) and hypertension (p = 0,002; PR = 3.51; 95% CI = 1.42 to 8.67). In conclusion, the smoking behavior and hypertension can lead to complications of coronary heart disease for patients with type in Diabetes Mellitus type 2 in Haji General Hospital year 2016. It needs awareness to check blood pressure regularly and eliminate the smoking habit as the prevention of complications of coronary heart disease for patients with diabetes mellitus type 2.Keywords: diabetes mellitus type 2, coronary hearth disease.

APA, Harvard, Vancouver, ISO, and other styles

34

Endo, M. "Surgical treatments for valvular heart disease with coronary heart disease." Japanese Journal of Cardiovascular Surgery 19, no. 2 (1989): 154–56. http://dx.doi.org/10.4326/jjcvs.19.154.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Saga, T. "Congenital heart diseases (1). Surgical treatment for pediatric coronary artery disease." Japanese Journal of Cardiovascular Surgery 18, no. 1 (1988): 47–49. http://dx.doi.org/10.4326/jjcvs.18.47.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Qiu, Shi, and Jinhui Sun. "Clinical Significance and Prognostic Factors of Simultaneous Heart Valve Surgery and Coronary Artery Bypass Grafting in Treating Patients with Valvular Heart Disease Complicated by Coronary Heart Disease." Tobacco Regulatory Science 7, no. 5 (September 30, 2021): 1203–13. http://dx.doi.org/10.18001/trs.7.5.37.

Full text

Abstract:

This study was designed to evaluate the clinical significance of simultaneous heart valve surgery and coronary artery bypass grafting for patients with valvular heart disease complicated by coronary heart disease and its influence on their prognosis. A total of 121 patients with valvular heart disease complicated by coronary heart disease who were surgically treated in our hospital from January 2013 to March 2017 were selected. The observation group (OG) (64 patients) underwent simultaneous valvular heart surgery and coronary artery bypass grafting. The control group (CG) (57 patients) underwent non-synchronous heart valve surgery and coronary artery bypass grafting. The operation, hospitalization, occurrence of adverse events and changes of cardiac function indexes of patients from the two groups were compared, and the factors affecting their prognosis were confirmed in multivariate analysis. The ventilator application time, postoperative ICU monitoring time, postoperative general ward time and total incidence of adverse events in the OG were lower than those in the CG (P<0.05). After treatment, the cardiothoracic ratio, left ventricular end-diastolic volume and BNP content in the two groups were markedly higher than before treatment, and the increase in the OG was more obvious (P<0.05); the left ventricular ejection fraction in both groups was markedly lower than that before treatment (P<0.05), and the decrease in the OG was more obvious (P<0.05). Multivariate analysis showed that hypertension, treatment methods, course of disease and age were independent risk factors affecting the prognosis of patients with valvular heart disease complicated by coronary heart disease. Simultaneous heart valve surgery and coronary artery bypass grafting can reduce the occurrence of adverse events and improve cardiac function indexes, which is worthy of clinical application. Hypertension, treatment methods, course of disease and age are independent risk factors affecting the prognosis of those patients.

APA, Harvard, Vancouver, ISO, and other styles

37

Ostroumova, O. D., V. M. Fomina, and E. A. Smolyarchuk. "A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial." Systemic Hypertension 12, no. 4 (December 15, 2015): 69–74. http://dx.doi.org/10.26442/sg29128.

Full text

Abstract:

In the article discusses questions of application of b-blockers (b-AB) for the treatment of arterial hypertension, coronary heart disease, chronic heart failure. The data from modern Russian and European recommendations about the place of b-AB in the treatment of cardiovascular diseases. Analyzed in detail the selection of b-AB inside the class from the standpoint of pharmacokinetics, selectivity, study in clinical studies. Data about efficiency and safety of application of metoprolol succinate for the treatment of arterial hypertension, coronary heart disease, chronic heart failure.

APA, Harvard, Vancouver, ISO, and other styles

38

Žaliaduonytė, Diana, Rita Kleinauskienė, Gintarė Muckienė, and Vytautas Zabiela. "Cardiovascular Disorder after Cardiotoxic Non-Hodking’s Lymphoma Treatment: A Case Report." Medicina 58, no. 4 (March 29, 2022): 489. http://dx.doi.org/10.3390/medicina58040489.

Full text

Abstract:

The non-Hodgkin’s lymphomas are a diverse group of lymphoid neoplasms that collectively rank fifth in cancer incidence and mortality. Patients treated with mediastinal radiotherapy and/or anthracycline-containing chemotherapy are known to have increased risks of coronary heart disease, valvular heart disease, and heart failure. This may be the result of cancer treatment cardiotoxicity or may be due to accelerated development of cardiovascular disease. We presented 41-year-old male who was admitted to the hospital because of congestive heart failure. He has a medical history of non-Hodgkin’s lymphoma treated with anthracycline-based chemotherapy and mediastinal radiotherapy almost 20 years ago. Echocardiography showed significant aortic valve stenosis, thickened and fibrotic pericardium. Coronary angiography showed diffuse three-vessel coronary artery disease. The patient was referred for surgical treatment. Aortic valve replacement, coronary artery bypass grafting and pericardiectomy were successfully performed, symptoms of heart failure reduced.

APA, Harvard, Vancouver, ISO, and other styles

39

Matskeplishvili, S. T., and S. Ya Arutyunova. "CONTEMPORARY APPROACHES TO ANTIPLATELET THERAPY IN CORONARY HEART DISEASE TREATMENT." Cardiovascular Therapy and Prevention 13, no. 4 (August 20, 2014): 69–74. http://dx.doi.org/10.15829/1728-8800-2014-4-69-74.

Full text

Abstract:

Transcutaneous interventions (PCI) are in growing usage as a method to revascularize myocardium in coronary heart disease. Double antiplatelet therapy, including acetylsalicylic acid clopidogrel, is now routinely prescribed for CHD patients preparing to undergo coronary intervention to prevent thrombosis. Reaching the maximum advantage in double antiplatelet therapy with control of platelet function after PCI may have additional value in cardiovascular morbidity and mortality prevention.

APA, Harvard, Vancouver, ISO, and other styles

40

Isomura, T. "Surgical treatment of valvular heart disease combined with coronary artery disease." Japanese Journal of Cardiovascular Surgery 19, no. 2 (1989): 156–58. http://dx.doi.org/10.4326/jjcvs.19.156.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Lopau, K., and C. Wanner. "Treatment rationale for coronary heart disease in advanced CKD." Herz 46, no. 3 (February 10, 2021): 221–27. http://dx.doi.org/10.1007/s00059-021-05025-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Okubo, Shinji, and Akihiro Fukuda. "Characteristics and treatment of elderly coronary heart disease patients." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 43, no. 6 (2006): 702–5. http://dx.doi.org/10.3143/geriatrics.43.702.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Karner, Anita, Madeleine Abrandt Dahlgren, and Bjorn Bergdahl. "Coronary heart disease: causes and drug treatment - spouses' conceptions." Journal of Clinical Nursing 13, no. 2 (February 2004): 167–76. http://dx.doi.org/10.1046/j.1365-2702.2003.00871.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Wait, Michael A. "Treatment of Coronary Heart Disease with Minimally Invasive Surgery." Baylor University Medical Center Proceedings 13, no. 2 (April 2000): 121–27. http://dx.doi.org/10.1080/08998280.2000.11927653.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Hamill, Sarah, and Nigel Ingram. "Gender disparities: assessment and treatment of coronary heart disease." British Journal of Cardiac Nursing 10, no. 10 (October 2, 2015): 494–502. http://dx.doi.org/10.12968/bjca.2015.10.10.494.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Vieweg, W. Victor R., Demetrios A. Julius, Antony Fernandez, Lawson R. Wulsin, Pramod K. Mohanty, Mary Beatty-Brooks, Mehrul Hasnain, and Anand K. Pandurangi. "Treatment of Depression in Patients with Coronary Heart Disease." American Journal of Medicine 119, no. 7 (July 2006): 567–73. http://dx.doi.org/10.1016/j.amjmed.2006.02.037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Kojima, Hajime. "Treatment of Depression in Patients with Coronary Heart Disease." American Journal of Medicine 120, no. 9 (September 2007): e13. http://dx.doi.org/10.1016/j.amjmed.2006.07.037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Schlierf, G., G. Schuler, R. Hambrecht, J. Niebauer, K. Hauer, G. Vogel, and W. Kubier. "Treatment of Coronary Heart Disease by Diet and Exercise." Journal of Cardiovascular Pharmacology 25 (1995): S32–34. http://dx.doi.org/10.1097/00005344-199500254-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Schlierf, G., G. Schuler, R. Hambrecht, J. Niebauer, K. Hauer, G. Vogel, and W. Kubier. "Treatment of Coronary Heart Disease by Diet and Exercise." Journal of Cardiovascular Pharmacology 25 (June 1995): S32–34. http://dx.doi.org/10.1097/00005344-199506001-00006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Chazova, T. E., and G. A. Melnichenko. "Diabetes mellitus and coronary heart disease." Problems of Endocrinology 44, no. 1 (February 1, 1998): 54. http://dx.doi.org/10.14341/probl199844154-54.

Full text

Abstract:

Atherosclerosis and related disorders of carbohydrate metabolism go beyond narrow cardiological problems and, in one way or another, are the subject of close attention of doctors of various specialties, including endocrinologists. In everyday practice, most endocrinologists leave the solution of issues related to hyperlipidemia “for later”, because, first, for many decades, full compensation for diabetes and hypothyroidism - conditions in which secondary hyperlipidemia is most common - was difficult ; secondly, there were no effective and safe means for treating hyperlipidemia, which made generations of doctors skeptical about the possibility of real correction of lipid metabolism disorders. Improving the methods for compensating for diabetes mellitus and the possibilities for treating hypothyroidism have brought clinicians to the problem of the need for additional therapy with lipid-lowering drugs, so the pathogenesis and treatment of hyperlipidemia are of great interest to them.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!